Funding Rounds
Theolytics

Theolytics Series B (2024, $23M)

Theolytics

Oncolytic viral therapies developer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $23.62M

Investors